EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   2:48:22 PM EDT
0.41
-0.05 (-10.73%)
Debt Financing / Related

Eyepoint Pharmaceuticals Announces Amendment To Crg Debt Facility Modifying 2020 And 2021 Revenue Covenants

Published: 10/08/2020 11:17 GMT
pSivida Corp (EYPT) - Eyepoint Pharmaceuticals Announces Amendment to Crg Debt Facility Modifying 2020 and 2021 Revenue Covenants.
Eyepoint Pharmaceuticals - Crg Waived Covenant Associated With Net Product Revenue of Dexycu and Yutiq for Twelve-month Period Ending on Dec 31.
Eyepoint Pharmaceuticals - Parties Agreed to Reduction of Dec 31, 2021 Net Product Revenue Covenant to $45 Million From $80 Million.